Jinan Ma
Impact in
- Health Informatics top 10%
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Papers in
- Oncology 16
- Inflammatory Biomarkers in Disease Prognosis 6
- Lung Cancer Research Studies 5
- Cancer Immunotherapy and Biomarkers 4
-
- Sarcoma Diagnosis and Treatment 3
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Chunhong Hu (17 shared papers)Tao Hou (9 shared papers)Fangwen Zou (8 shared papers)Shun Jiang (6 shared papers)Yapeng Wang (4 shared papers)Haixia Zhang (1 shared paper)Wenhao Luo (1 shared paper)Sisi Wang (3 shared papers)
- Journals
- Medicine (3 papers)Frontiers in Oncology (3 papers)Journal of Clinical Oncology (2 papers)Scientific Reports (1 paper)Expert Review of Vaccines (1 paper)
- Partner nations
- ChinaUnited StatesVietnam
In The Last Decade
Jinan Ma
39 papers receiving 420 citations
Peers
Comparison fields: 5 of 69
- Health Informatics 11
- Cancer Research 79
- Oncology 137
- Otorhinolaryngology 12
- Pulmonary and Respiratory Medicine 85
Countries citing papers authored by Jinan Ma
This map shows the geographic impact of Jinan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinan Ma more than expected).
Fields of papers citing papers by Jinan Ma
This network shows the impact of papers produced by Jinan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinan Ma. The network helps show where Jinan Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinan Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 45 | |
| 2 | 2020 | 42 | |
| 3 | 2020 | 38 | |
| 4 | 2020 | 31 | |
| 5 | 2019 | 30 | |
| 6 | 2021 | 22 | |
| 7 | 2024 | 20 | |
| 8 | 2014 | 19 | |
| 9 | 2015 | 17 | |
| 10 | 2018 | 16 | |
| 11 | Decitabine reverses gefitinib resistance in PC9 lung adenocarcinoma cells by demethylation of RASSF1A and GADD45β promoter. | 2019 | 14 |
| 12 | 2022 | 13 | |
| 13 | 2020 | 12 | |
| 14 | 2021 | 10 | |
| 15 | 2020 | 10 | |
| 16 | 2020 | 9 | |
| 17 | 2022 | 8 | |
| 18 | 2015 | 8 | |
| 19 | 2020 | 7 | |
| 20 | 2024 | 6 |
About Jinan Ma
Jinan Ma is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Surgery, having authored 43 papers that have together received 429 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (6 papers), Lung Cancer Research Studies (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Head and Neck Cancer Studies (3 papers), Circular RNAs in diseases (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Testicular diseases and treatments (2 papers). The work is most often cited by research in Health Informatics (11 citations), Cancer Research (79 citations), Oncology (137 citations), Otorhinolaryngology (12 citations) and Pulmonary and Respiratory Medicine (85 citations). Jinan Ma has collaborated with scholars based in China, United States and Vietnam. Frequent co-authors include Chunhong Hu, Tao Hou, Fangwen Zou, Shun Jiang, Yapeng Wang, Haixia Zhang, Wenhao Luo, Sisi Wang, Fang Ma and Yeqian Feng. Their work appears in journals such as Medicine, Frontiers in Oncology, Journal of Clinical Oncology, Scientific Reports and Expert Review of Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.